Who is the CEO of Parataxis Korea?

According to the DART company overview, Parataxis Korea's representative director is Andrew Kim (name as registered in Korean). The company was founded on 2015-09-17.

Where is Parataxis Korea listed?

Parataxis Korea trades on the Korea Exchange KOSDAQ market under the ticker 288330. Its fiscal year ends in December.

What were Parataxis Korea's latest quarterly results?

In Q2 2026, Parataxis Korea reported an operating loss of ₩2.2bn. Figures come from reports filed on DART.

Does Parataxis Korea pay a dividend?

Parataxis Korea did not pay a cash dividend for fiscal 2025, according to its annual report.

Does Parataxis Korea have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: 4 quarters of losses (operating loss in each of the last four quarters); M&A / stake deal (merger, spin-off or acquisition/sale of shares in another company (90 days)). These are factual flags, not investment advice.

Which companies are in the same industry as Parataxis Korea?

Under the Korean Standard Industrial Classification recorded on DART, Parataxis Korea is grouped with 15 other listed companies in other professional & technical services. The most covered in Korean news over the past 30 days are GC Cell, NGeneBio and Doosan Tesna.

Parataxis Korea KRX:288330KOSDAQ

파라택시스코리아 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h5

Articles, 7 days5

DART filings, 7 days4

Articles tracked5since Sep 11

In Q2 2026, Parataxis Korea reported an operating loss of ₩2.2bn. Parataxis Korea (파라택시스코리아) appeared in 5 Korean news articles and 4 DART filings over the past seven days. Coverage peaked on Oct 7 with 4 articles. The most common catalyst was stakes & m&a (2). It was most often mentioned alongside Parataxis Ethereum.

Filing signals M&A / stake deal 4 quarters of losses Screener

Parataxis Korea quarterly results consolidated, KRW

Quarter	Operating profit	Net income
Q2 2026	−₩2.2bn	−₩5.5bn
Q1 2026	−₩2.1bn	−₩2.6bn
Q4 2025 derived	−₩2.1bn	−₩19.2bn
Q3 2025	−₩3.4bn	−₩3.5bn
Q2 2025	−₩4.7bn	−₩4.6bn
Q1 2025	−₩5.0bn	−₩4.9bn
Q4 2024 derived	−₩3.4bn	−₩4.2bn
Q3 2024	−₩4.7bn	−₩4.5bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Parataxis Korea top stories 2 weeks, by number of outlets

1
파라택시스이더리움, 파라택시스코리아 흡수합병 철회
1 outlets · 2 articlesFirst report Oct 7 08:58 이데일리Parataxis Ethereum
2
파라택시스이더리움, 파라택시스코리아 합병 철회…상장폐지 관련 불확실성에 계약 해제
1 outlets · 1 articlesFirst report Oct 7 09:02 벤처스퀘어Negative newsParataxis Ethereum
3
[공시] 파라택시스코리아 기타주요경영사항 (회사합병 결정 및 임시주주총회 소집결의 철회)
1 outlets · 1 articlesFirst report Oct 6 16:29 스페셜타임스Stake / acquisition
4
파라택시스이더리움, 파라택시스코리아와 합병 결정 철회
1 outlets · 1 articlesFirst report Oct 7 09:04 뉴스핌Stake / acquisitionParataxis Ethereum

Latest Parataxis Korea news Korean headlines

09:04

파라택시스이더리움, 파라택시스코리아와 합병 결정 철회
뉴스핌Stake / acquisitionParataxis Ethereum
09:02

Major파라택시스이더리움, 파라택시스코리아 합병 철회…상장폐지 관련 불확실성에 계약 해제
벤처스퀘어Negative newsParataxis Ethereum
08:58
파라택시스이더리움, 파라택시스코리아 흡수합병 철회
이데일리Parataxis Ethereum
1 more on this story · 1 outlets
- 파라택시스이더리움, 파라택시스코리아 흡수합병 철회이데일리 · 09:00
Oct 616:29

Major[공시] 파라택시스코리아 기타주요경영사항 (회사합병 결정 및 임시주주총회 소집결의 철회)
스페셜타임스Stake / acquisition

Articles per day 2 weeks

Company profile

CEO: Andrew Kim
Industry: Other professional & technical services
Founded: 2015-09-17
Fiscal year-end: December
Head office: 경기도 성남시
Website: bridgebiorx.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Other professional & technical services

All in industry

Company	Latest quarter op. profit	Articles 30d
GC Cell	−₩1.0bn	88
NGeneBio	−₩1.2bn	19
Doosan Tesna	₩9.9bn	16
C&R Research	₩176m	14
Fescaro	₩531m	7
WOOJIN Ntec	₩1.0bn	6
Nepes Ark	₩5.1bn	3
Macrogen	₩698m	2

Compare Parataxis Korea side by side with these companies

Parataxis Korea DART filings

Oct 616:12

Merger / spin-off [기재정정]주요사항보고서(회사합병결정)
Capital & M&A
Oct 616:06

Other [기재정정]주주명부폐쇄기간또는기준일설정 (임시주주총회-철회)
Other
Oct 616:06

Other [기재정정]주주총회소집결의 (임시주주총회-철회)
Other
Oct 616:06

Merger / spin-off 기타주요경영사항 (회사합병 결정 및 임시주주총회 소집결의 철회)
Capital & M&A

Catalysts 2 weeks

Stakes & M&A2
Risk & warnings1

Mentioned alongside 2 weeks

1 Parataxis EthereumKOSDAQ 4

Parataxis Korea FAQ

Who is the CEO of Parataxis Korea?: According to the DART company overview, Parataxis Korea's representative director is Andrew Kim (name as registered in Korean). The company was founded on 2015-09-17.
Where is Parataxis Korea listed?: Parataxis Korea trades on the Korea Exchange KOSDAQ market under the ticker 288330. Its fiscal year ends in December.
What were Parataxis Korea's latest quarterly results?: In Q2 2026, Parataxis Korea reported an operating loss of ₩2.2bn. Figures come from reports filed on DART.
Does Parataxis Korea pay a dividend?: Parataxis Korea did not pay a cash dividend for fiscal 2025, according to its annual report.
Does Parataxis Korea have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: 4 quarters of losses (operating loss in each of the last four quarters); M&A / stake deal (merger, spin-off or acquisition/sale of shares in another company (90 days)). These are factual flags, not investment advice.
Which companies are in the same industry as Parataxis Korea?: Under the Korean Standard Industrial Classification recorded on DART, Parataxis Korea is grouped with 15 other listed companies in other professional & technical services. The most covered in Korean news over the past 30 days are GC Cell, NGeneBio and Doosan Tesna.